Cross-presentation of cell-associated antigens by dendritic cells

Current Topics in Microbiology and Immunology

Volumn 276, Issue , 2003, Pages 261-275

  Larsson, M ^a   Fonteneau, J F ^a   Bhardwaj, N ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; CD11B ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CELL ANTIGEN; GLYCOPROTEIN P 15095; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TOLL LIKE RECEPTOR;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; APOPTOSIS; B LYMPHOCYTE; CELL MATURATION; CELLULAR IMMUNITY; CROSS REACTION; CROSS TOLERANCE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EPSTEIN BARR VIRUS; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNOSTIMULATION; IMMUNOSURVEILLANCE; INFLUENZA VIRUS; LANGERHANS CELL; LIVER SINUSOID; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMORY CELL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; VACCINIA VIRUS; VIRUS IMMUNITY; VIRUS LATENCY; VIRUS REPLICATION;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; INFLUENZA VIRUS; SIMPLEXVIRUS; VACCINIA VIRUS;

EID: 0038407533     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-662-06508-2_12     Document Type: Review

References (62)

1. Albert ML, Jegathesan M, Darnell RB: Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat Immunol 2001, 2:1010-1017.
2. Albert ML, Pearce SFA, Francisco LM, Sauter B, Roy P, Silverstein RL, Bhardwaj N: Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 1998a, 188:1359-1368.
3. Albert ML, Sauter B, Bhardwaj N: Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998b, 392:86-89.
4. Arrode G, Boccaccio C, Lule J, Allart S, Moinard N, Abastado JP, Alam A, Davrinche C: Incoming human cytomegalovirus pp65 (UL83) contained in apoptotic infected fibroblasts is cross-presented to CD8(+) T cells by dendritic cells. J Virol 2000, 74:10018-10024.
5. Bachmann MF, Lutz MB, Layton GT, Harris SJ, Fehr T, Rescigno M, Ricciardi-Castagnoli P: Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes. Eur. J. Immunol. 1996, 26:1-7.
6. Bennett SRM, Carbone FR, Karamalis F, Flavell RA, Miller JFAP, Heath WR: Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 1998, 393:478-480.
7. Bennett SRM, Carbone FR, Karamalis F, Miller JJAP, Heath WR: Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J. Exp. Med. 1997, 186:65-70.
8. Bevan MJ: Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 1976, 143:1283-1288.
9. Blake N, Haigh T, Shaka'a G, Croom-Carter D, Rickinson A: The importance of exogenous antigen in priming the human CD8(+) T cell response: lessons from the EBV nuclear antigen EBNA1. J Immunol 2000, 165:7078-7087. High frequency of CTLs against EBNA1 was detected in the blood of EBV-seropositive donors. The authors conclude that CTL responses toward EBNA1 are initiated by an exogenous HLA class I presentation pathway, as epitopes from EBNA1 are poorly generated by the classic endogenous pathway of HLA class I presentation. Furthermore, the observation that DCs cocultured with soluble EBNA1 are able to activate EBNA1-specific CTL supports their conclusion.
10. Castellino F, Boucher PE, Eichelberg K, Mayhew M, Rothman JE, Houghton AN, Germain RN: Receptor-mediated uptake of antigen/heat shock protein complexes results in Major Histocompatibility Complex class I antigen presentation via two distinct processing pathways. J. Exp. Med. 2000, 191:1957-1964.
11. Daheshia M, Feldman L, Rouse B: Heres simplex virus latency and immune response. Current Opinion in Microbiology 1998, 1:430-435.
12. Demkowitz WE, Jr. Littaua RA, Wang J, Ennis FA: Human cytotoxic T-cell memory: long-lived responses to vaccinia virus. J. Virol. 1996, 70:2627-2631.
13. - DCs are able to cross-present OVA epitopes.
14. Dhodapkar MV, Bhardwaj N: Active immunization of humans with dendritic cells. J. Clin. Immunol. 2000, 20:167-174.
15. Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N: Antigen specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 2001, 193:233-238.
16. Engelmayer J, Larsson M, Subklewe M, Chahroudi A, Schmaljohn A, William C, Steinman RM, Bhardwaj N: Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol. 1999, 163:6762-6768.
17. Ferlazzo G, Semino C, Spaggiari GM, Meta M, Mingari MC, Melioli G: Dendritic cells efficiently cross-prime HLA class I-restricted cytolytic T lymphocytes when pulsed with both apoptotic and necrotic cells but not with soluble cell-derived lysates. Int Immunol 2000, 12:1741-1747.
18. Fugier-Vivier I, Servet-Delprat C, Rivailler P, Rissoan M-C, Liu Y-J, Rabourdin-Combe C: Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of DC and T cells. Submitted 1997.
19. Hahn G, Jores R, Mocarski E: Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci USA 1998, 95:3937-3942.
20. Harding CV, Song R: Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molcules. J. Immunol. 1994, 153:4925-4933.
21. Heath WR, Carbone FR: Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 2001, 19:47-64.
22. Heath WR, Kurts C, Miller JFAP, Carbone F: Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J. Exp. Med. 1998, 187:1549-1553.
23. Herr W, Ranieri E, Olson W, Zarour H, Gesualdo L, Storkus WJ: Mature dendritic cells pulsed with freeze-thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4(+) and CD8(+) T lymphocyte responses. Blood 2000, 96:1857-1864.
24. Huang AYC, Bruce AT, Pardoll DM, Levitsky HI: In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. Immunity 1996, 4:349-355.
25. +). This subset of rat DCs may represent the BM-derived APCs responsible for peripheral tolerance.
26. Jenne L, Hauser C, Arrighi JF, Saurat JH, Hugin AW: Poxvirus as a vector to transduce human dendritic cells for immunotherapy: abortive infection but reduced APC function. Gene Ther 2000, 7:1575-1583.
27. Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH: Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000, 192:1213-1222.
28. Kovacsovics-Bankowski M, Rock KL: A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 1995, 267:243-246.
29. Kruse M, Rosorius O, Kratzer F, Stelz G, Kuhnt C, Schuler G, Hauber J, Steinkasserer A: Mature dendritic cells infected with herpes simplex virus type I exhibit inhibited T cell stimulatory capacity. J. Virol. 2000, 74:7127-7136.
30. + T cell division, restricted only by the donor HLA allele, was observed, demonstrating that DCs were sufficient to cross-present self-antigens.
31. Kurts C, Carbone FR, Barnden M, Blanas E, Allison J, Heath WR, Miller JF: CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J. Exp. Med. 1997, 186:2057-2062.
32. Larsson M, Fonteneau JF, Bhardwaj N: Dendritic cells resurrect antigens from dead cells. Trends Immunol. 2001a, 22:141-148.
33. Larsson M, Fonteneau JF, Lee A, Bhardwaj N: Interations of viruses with dendritic cells. In: Dendritic Cells; 2001b.
34. Larsson M, Fonteneau J, Somersan S, Sanders C, Bickham K, Thomas E, Mahnke K, Bhardwaj N: Efficiency of cross presentation of vaccinia virus-derived antigens by human dendritic cells. Eur J Immunol 2001c, 31:3432-3442. The authors quantify the efficiency of human DC cross-presention of vaccinia virus-derived antigen by using an antigen-specific CD8+ CTL clone as responder cells. They show that low quantities of necrotic or apoptotic infected cells are equally efficient sources of antigen for cross-presentation. Maturation of DCs, especially with CD40L, is required to achieve efficient cross-presentation that can approach the presentation efficiency of a high quantity of exogenously added peptides.
35. Lenz LL, Butz EA, Bevan MJ: Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens. J. Exp. Med. 2000, 192:1135-1142. Using a chimeric mice model, the authors show that BM-derived APCs are required to induce CTL responses against Listeria monocytogenes and vaccinia virus. Interestingly, CTL responses against LCMV can develop in the absence of BM-derived APCs, suggesting that CTL responses can be initiated by direct presentation of viral antigens by non-BM-derived cells.
36. Li M, Davey GM, Sutherland RM, Kurts C, Lew AM, Hirst C, Carbone FR, Heath WR: Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J Immunol 2001, 166:6099-6103.
37. + T cell-derived lymphokines.
38. Machy P, Serre K, Leserman L: Class I-restricted presentation of exogenous antigen acquired by Fcgamma receptor-mediated endocytosis is regulated in dendritic cells. Eur. J. Immunol. 2000, 30:848-857.
39. Maecker HT, Ghanekar SA, Suni MA, He XS, Picker LJ, Maino VC: Factors affecting the efficiency of CD8+ T cell cross-priming with exogenous antigens. J Immunol 2001, 166:7268-7275.
40. Menges M, Rossner S, Voigtlander C, Schindler H, Kukutsch NA, Bogdan C, Erb K, Schuler G, Lutz MB: Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med 2002, 195:15-21.
41. Norbury C, Princiotta M, Bacik I, Brutkiewicz R, Wood P, Elliott T, Bennink J, Yewdell J: Multiple antigen-specific processing pathways for activating naive CD8+ T cells in vivo. J Immunol 2001, 166:4355-4362.
42. Pfeifer JD, Wick MJ, Roberts RL, Findlay K, Normark SJ, Harding CV: Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 1993, 361:359-362.
43. Ploegh HL: Viral strategies of immune evasion. Science 1998, 280:248-253.
44. + T cells.
45. Ramachandra L, Song R, Harding CV: Phagosomes are fully competent antigen-processing organelles that mediate the formation of peptide: class II MHC complexes. J. Immunol. 1999, 162:3263-3272.
46. Restifo N: Building better vaccines: how apoptotic cell death can induce inflammation and activate innate and adaptive immunity. Curr Opin Immunol 2000, 12:597-603.
47. Riegler S, Herbart H, Einsele H, Brossart P, Jahn G, Sinzger C: Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. J Gen Virol 2000, 81:393-399.
48. + T cells from immune complexes. The pathway is TAP dependent and involves an active and size-dependent transport of specific antigens across endosomal membrane to the cytosol inside DCs.
49. Salio M, Cella M, Suter M, Lanzavecchia A: Inhibition of dendritic cell maturation by herpes simplex virus. Eur. J. Immunol. 1999, 29:3245-3253.
50. Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N: Consequences of cell death. Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 2000, 191:423-434.
51. Servet-Delprat C, Vidalain PO, Azocar O, Le Deist F, Fischer A, Rabourdin-Combe C: Consequences of Fas-mediated human dendritic cell apoptosis induced by measles virus. J Virol 2000a, 74:4387-4393.
52. Servet-Delprat C, Vidalain PO, Bausinger H, Manie S, Le Deist F, Azocar O, Hanau D, Fischer A, Rabourdin-Combe C: Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells. J. Immunol. 2000b, 164:1753-1760.
53. - mice, This study demonstrates that nonhematopoietic cells are unable to directly initiate a immune response against poliovirus and that TAP-dependent antigen cross-presentation by bone marrow pAPCs is sufficient for the priming of poliovirus specific CTLs.
54. Sigal LJ, Rock KL: Bone Marrow-derived Antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation. J. Exp. Med. 2000, 192:1143-1150. Using transgenic mice, the authors show that cross-presentation by BM-derived APCs is required for the generation of CTL responses against LCMV and influenza antigens. A functional TAP is required to present the majority of studied epitopes. However, a TAP-independent pathway can be used by BM-derived APCs to generate certain epitopes when they are expressed in high quantities.
55. Singh-Jasuja H, Toes RE, Spee P, Munz C, Hilf N, Schoenberger SP, Ricciardi-Castagnoli P, Neefjes J, Rammensee HG, Arnold-Schild D, Schild H: Cross-presentation of glycoprotein 96-associated antigens on Major Histocompatibility Complex class I molecules requires receptor-mediated endocytosis. J. Exp. Med. 2000, 191:1965-1974.
56. Sotomayor EM, Borrello I, Rattis F-M, Abrams J, Staveley-O'Carroll K, Levitsky HI: Cross-presentation of tumor by bone marrow derived antigen presenting cells is the dominant mechanism in the induction of T cell tolerance during B-cell lymphoma progression. Blood 2001, 98:1070-1077.
57. Sotomayor EM, Borrello I, Tubb E, Rattis FM, Bien H, Lu Z, Fein S, Schoenberger S, Levitsky HI: Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40. Nat Med 1999, 5:780-787.
58. Subklewe M, Paludan C, Tsang ML, Steinman RM, Münz C: Dendritic cells cross-present latency gene products from Epstein-Barr Virus-transformed B cells and expand tumor-reactive CD8(+) killer T cells. J. Exp. Med. 2001, 193:405-412.
59. Tabi Z, Moutaftsi M, Borysiewicz LK: Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens. J Immunol 2001, 166:5695-5703.
60. Villadangos JA, Ploegh HL: Proteolysis in MHC class II antigen presentation: who's in charge? Immunity 2000, 12:233-239.
61. Yewdell J, Anton LC, Bacik I, Schubert U, Snyder HL, Bennink JR: Generating MHC class I ligands from viral gene products. Immunol Rev 1999a, 172:97-108.
62. Yewdell JW, Norbury CC, Bennink JR: Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines. Adv Immunol 1999b, 73:1-77.